Brandt J, Schüller H
Department of Cardiothoracic Surgery, Lund University Hospital, Sweden.
Clin Cardiol. 1994 Sep;17(9):495-8. doi: 10.1002/clc.4960170907.
Symptomatic sinus node disease is a common indication for permanent pacemaker implantation. Single-chamber ventricular (VVI) pacing, single-chamber atrial (AAI) stimulation, and dual-chamber (DDD or DDI) systems are used to a varying extent at different implanting centers. Hemodynamic and clinical studies relevant to the choice of pacing mode in these patients are reviewed. The data currently available strongly support the use of pacing systems providing atrial stimulation. The choice between single-chamber atrial or dual-chamber pacing can be based on the relative importance assigned to a number of factors: Hemodynamic aspects, the risk of ventricular lead problems, cost, and complexity aspects favor AAI pacing, whereas patients with a substantial risk of developing atrioventricular block should receive a DDD or DDI unit.
有症状的窦房结疾病是永久性起搏器植入的常见适应证。单腔心室(VVI)起搏、单腔心房(AAI)刺激和双腔(DDD或DDI)系统在不同的植入中心有不同程度的应用。本文综述了与这些患者起搏模式选择相关的血流动力学和临床研究。目前可得的数据有力地支持使用能提供心房刺激的起搏系统。单腔心房起搏或双腔起搏之间的选择可基于多个因素的相对重要性:血流动力学方面、心室导线问题的风险、成本以及复杂性方面有利于AAI起搏,而发生房室传导阻滞风险较高的患者应接受DDD或DDI装置。